Kothari Fermentation & Biochem Ltd Board Approves Director Reappointments and Remuneration Revisions

1 min read     Updated on 08 Apr 2026, 02:25 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Kothari Fermentation & Biochem Ltd's board meeting on April 08, 2026, approved reappointment of Mr. Pramod Kumar Kothari as Chairman & Managing Director at Rs. 6,00,000/- monthly and Mrs. Kavita Devi Kothari as Whole Time Director at Rs. 5,75,000/- monthly. Both three-year appointments from April 1, 2026, to March 31, 2029, require shareholder approval and follow Nomination and Remuneration Committee recommendations.

powered bylight_fuzz_icon
37184100

*this image is generated using AI for illustrative purposes only.

Kothari Fermentation & Biochem Ltd announced significant board decisions regarding director reappointments and remuneration revisions following a board meeting held on April 08, 2026. The company, which operates as an ISO 22000:2018 and HALAL certified organization, disclosed these developments in compliance with SEBI regulations.

Board Meeting Outcomes

The Board of Directors convened on Wednesday, April 08, 2026, from 10:30 AM to 12:00 PM to deliberate on key appointments. The meeting resulted in approval of reappointments and remuneration revisions for two senior directors, based on recommendations from the Nomination and Remuneration Committee.

Director Reappointments and Remuneration Details

The board approved significant changes to the leadership structure:

Position Director New Monthly Remuneration Term Period
Chairman & Managing Director Mr. Pramod Kumar Kothari Rs. 6,00,000/- April 1, 2026 - March 31, 2029
Whole Time Director Mrs. Kavita Devi Kothari Rs. 5,75,000/- April 1, 2026 - March 31, 2029

Mr. Pramod Kumar Kothari Reappointment

Mr. Pramod Kumar Kothari (DIN: 00086145) has been reappointed as Chairman and Managing Director for a three-year term. His monthly remuneration has been revised to Rs. 6,00,000/-. The appointment makes him liable to retire by rotation and requires shareholder approval in the forthcoming general meeting.

Mrs. Kavita Devi Kothari Reappointment

Mrs. Kavita Devi Kothari (DIN: 00120415) has been reappointed as Whole Time Director with revised monthly remuneration of Rs. 5,75,000/-. Similar to the Chairman's appointment, her three-year term is subject to shareholder approval and ratification.

Family Relationships and Corporate Governance

The company disclosed important relationships between directors as required by regulations:

  • Mr. Pramod Kumar Kothari and Mrs. Kavita Devi Kothari are husband and wife
  • Both are parents of Mr. Siddhant Kothari, Whole-Time Director
  • Both are parents-in-law of Ms. Janhavi Kothari, Executive Director (Purchase Department)

Regulatory Compliance

The announcements comply with Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, and follow the company's Policy on Determination of Materiality of Events/Information. The company has also uploaded the intimation on its website at www.kothariyeast.in/investors for stakeholder access.

All appointments are contingent upon shareholder approval in the upcoming general meeting, ensuring proper corporate governance protocols are followed.

Historical Stock Returns for Kothari Fermentation & Biochem

1 Day5 Days1 Month6 Months1 Year5 Years
-0.40%+20.01%+11.40%-12.81%-37.35%-16.21%

How might the significant remuneration increases for both directors impact the company's operational costs and profitability margins over the next three years?

What strategic initiatives or expansion plans could justify the substantial salary revisions for the leadership team?

Will the concentration of family members in key executive positions raise any corporate governance concerns among institutional investors?

Kothari Fermentation & Biochem
View Company Insights
View All News
like20
dislike

Kothari Fermentation Opens One-Year Special Window for Physical Share Transfer and Dematerialisation

2 min read     Updated on 06 Apr 2026, 03:32 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Kothari Fermentation and Biochem Ltd has opened a special one-year window from February 5, 2026, to February 4, 2027, for transfer and dematerialisation of physical securities sold or purchased before April 1, 2019. Following SEBI circular requirements, the company published newspaper notices on April 6, 2026, in Financial Express and Jansatta. Eligible investors can submit requests to RTA Abhipra Capital Ltd with original certificates and transfer deeds, while ensuring updated KYC details to avoid delays.

powered bylight_fuzz_icon
37015331

*this image is generated using AI for illustrative purposes only.

Kothari Fermentation & Biochem Ltd has announced the opening of a special window for investors to facilitate the transfer and dematerialisation of physical securities. This initiative follows SEBI Circular No. HO/38/13/11(2)/2026-MIRSD-PODI/3750/2026 dated January 30, 2026.

Special Window Details

The company has established a one-time special window that will remain operational for a full year, providing investors with ample opportunity to complete their transfer and dematerialisation requirements.

Parameter: Details
Window Period: February 5, 2026 to February 4, 2027
Duration: One year
Eligibility: Securities sold/purchased before April 1, 2019
Regulatory Basis: SEBI Circular dated January 30, 2026

Newspaper Publication Compliance

In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published reminder notices on April 6, 2026, in two newspapers:

  • Financial Express (English)
  • Jansatta (Regional language)

This publication serves as a continuation of the company's previous disclosure dated February 7, 2026, ensuring comprehensive investor awareness about the special window facility.

Eligible Cases and Documentation

The special window accommodates various scenarios for investor convenience:

  • Securities sold or purchased before April 1, 2019 meeting SEBI eligibility criteria
  • Previously submitted transfer requests that were rejected, returned, or not processed due to document deficiencies
  • Cases requiring process corrections or other procedural issues

Required Documentation:

  • Original share certificate(s)
  • Duly executed transfer deed (executed prior to April 1, 2019)
  • Other documents as specified in the SEBI circular

Application Process

Eligible investors must submit their transfer-cum-demat requests to the company's Registrar and Transfer Agent:

Contact Details: Information
RTA Name: Abhipra Capital Ltd
Address: Abhipra Complex, Dilkush Industrial Area, A-387, G.T. Kamal Road, Azadpur, New Delhi - 110033
Telephone: +91-11-42390783
Email: rta@abhipra.com

Important Guidelines

The company has highlighted several key points for investor attention:

  • Account Updates: Investors should ensure their account and KYC details are current to avoid processing delays
  • Exclusions: Securities transferred to IEPF (Investor Education and Protection Fund) are not eligible
  • Dispute Cases: Matters involving disputes will not be considered under this window

Regulatory Framework

This special window initiative aligns with SEBI's broader framework for facilitating the dematerialisation of physical securities and improving market efficiency. The one-year duration provides sufficient time for eligible investors to complete the necessary procedures while ensuring compliance with regulatory requirements.

The company's proactive approach in publishing newspaper reminders demonstrates its commitment to ensuring maximum investor participation in this special facility, helping shareholders transition from physical to electronic form of securities holding.

Historical Stock Returns for Kothari Fermentation & Biochem

1 Day5 Days1 Month6 Months1 Year5 Years
-0.40%+20.01%+11.40%-12.81%-37.35%-16.21%

Will SEBI extend similar special dematerialization windows to other listed companies facing comparable physical securities backlogs?

How might the completion rate of this special window influence SEBI's future policy on mandatory dematerialization timelines?

What impact could widespread adoption of such special windows have on the overall liquidity and trading volumes of affected securities?

Kothari Fermentation & Biochem
View Company Insights
View All News
like20
dislike

More News on Kothari Fermentation & Biochem

1 Year Returns:-37.35%